Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS

Agata Bielecka-Dabrowa1,2, Paulina Gasiorek2, Andrzej Wittczak2

  • 1Heart Failure Unit, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.

Insights

Diastolic dysfunction predicts poor outcomes in embolic strokes of undetermined origin (ESUS) patients under 65. Early diastolic mitral annular velocity (E/E') is a key predictor of recurrent stroke and composite endpoints.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Diagnostics

Background:

  • Embolic strokes of undetermined etiology (ESUS) represent a significant proportion of ischemic strokes.
  • Predicting prognosis in younger ESUS patients (<65 years) requires identification of specific risk factors.
  • Echocardiographic and hemodynamic parameters may offer insights into stroke risk.

Purpose of the Study:

  • To identify echocardiographic, hemodynamic, and biochemical predictors of unfavorable prognosis in patients under 65 with ESUS.
  • To assess the association of these predictors with cardiovascular hospitalizations, recurrent stroke, and composite endpoints.

Main Methods:

  • A cohort of 64 ESUS patients and 36 controls underwent echocardiography and non-invasive hemodynamic assessment.
  • Biomarkers were measured, and patients were followed for 12 months.
  • Multivariate analysis was used to identify independent predictors of adverse outcomes.

Main Results:

  • The ratio of early diastolic transmitral flow to early diastolic mitral annular motion (E/E") was an independent predictor of recurrent stroke (OR 0.75, p=0.01).
  • E/E" was also associated with a composite endpoint of death, hospitalization, and recurrent stroke (OR 1.90, p=0.01).
  • Mean early diastolic mitral annular velocity (E') was linked to cardiovascular hospitalizations (OR 0.75, p=0.01).

Conclusions:

  • Indices of diastolic dysfunction, particularly E/E", are significantly associated with unfavorable prognosis in younger ESUS patients.
  • Outpatient cardiac monitoring, especially in the first two months post-hospitalization, is crucial for detecting atrial fibrillation (AF).
  • These findings highlight the importance of diastolic function assessment in managing ESUS.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
131
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
174
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
153
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
78
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
134